Generic Name
AfliberceptPacks Price
- Inj 40 mg/1ml: 1Vial: 84150.00: 99000.00
Eylea
Therapeutic Group
Ocular Vascular Disorder AgentsIndication Dosage
Neovascular (wet) Age-related Macular Degeneration:
By Intravitreal Inj:
- Adult: Initially 2 Mg Once A Month For 3 Months, Then 2 Mg Every 2 Months, Review Treatment Frequency After 12 Months
Macular Oedema Secondary To Retinal Vein Occlusion:
By Intravitreal Inj:
- Adult: Initially 2 Mg Once A Month Until Maximum Visual Acuity Is Achieved Or There Are No Signs Of Disease Activity (discontinue Treatment If No Improvement In Visual And Anatomic Outcomes)
Diabetic Macular Oedema:
By Intravitreal Inj:
- Adult: Initially 2 Mg Once A Month For 5 Months, Then Maintenance 2 Mg Every 2 Months, Review Treatment Frequency After 12 Months (discontinue Treatment If No Improvement In Visual And Anatomic Outcomes)
Myopic Choroidal Neovascularisation:
By Intravitreal Inj:
- Adult: 2 Mg For 1 Dose, If Visual Or Anatomic Outcomes Indicate That Disease Persists, Additional Doses May Be Administered; The Interval Between 2 Doses Should Be Greater Than 1 Month
Content
- Inj: Per ml: Aflibercet 40mg, Solution For Injection.
Pregnancy
Avoid Unless Potential Benefit Outweighs Risk
Stability
- Vascular Endothelial Growth Factor Inhibitor
Contra Indications
- Ocular Or Periocular Infection, Severe Intra-ocular Inflammation, Irreversible Ischaemic Visual Function Loss Cautions: Diabetic Patients With Uncontrolled Hypertension, Active Systemic Infection, Discontinue Treatment If Stage 3 Or 4 Macular Holes Develop Or In The Event Of A Retinal Break Or Rhegmatogenous Retinal Detachment (consult Product Literature For Full Details), Patients At Risk Of Retinal Pigment Epithelial Tear, Poorly Controlled Glaucoma.
Precautions
- Ocular Or Periocular Infection, Severe Intra-ocular Inflammation, Irreversible Ischaemic Visual Function Loss Cautions: Diabetic Patients With Uncontrolled Hypertension, Active Systemic Infection, Discontinue Treatment If Stage 3 Or 4 Macular Holes Develop Or In The Event Of A Retinal Break Or Rhegmatogenous Retinal Detachment (consult Product Literature For Full Details), Patients At Risk Of Retinal Pigment Epithelial Tear, Poorly Controlled Glaucoma.
Lactation
- Contraindicated, Discontinue Breast Feeding.
Side Effects
- Cataract Formation
- Corneal Abrasion
- Oedema Or Haemorrhage
- Conjunctival Hyperaemia
- Eye Pain
- Eyelid Oedema
- Foreign Body Sensation In Eye
- Increased Lacrimation
- Injection-site Haemorrhage
- Injection-site Pain
- Ocular Hyperaemia
- Punctate Keratitis
- Raised Intra-ocular Pressure
- Reduced Visual Acuity
- Blurred Vision
- Retinal Degeneration
- Retinal Pigment Epithelium Detachment
- Retinal Pigment Epithelium Tear
- Vitreous Detachment
- Vitreous Floaters
- Vitreous Haemorrhage.
- Rare: Hypopyon
- Vitritis
- Retinal Detachment
- Retinal Tear
- Uveitis
Author
Shahid Arif